Spirig HealthCare AG - Pazopanib Spirig HC 200 mg, Filmtabletten | | 69276 | | 01 | | Pazopanib Spirig HC 200 mg | | Filmtabletten | | L01EX03 | | Pazopanib | | 06.10.2023 | | |
| Composition | pazopanibum 200 mg ut pazopanibi hydrochloridum, cellulosum microcristallinum, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), polysorbatum 80, pro compresso obducto corresp. natrium max. 1.10 mg. | Packungsbestandteile | | Coated tablets | | Active Agent | Dose |
---|
Pazopanibum | 200 mg |
| | Inactive agents | Dose | additional_information |
---|
(Rubrum) | | | Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Überzug | Macrogol | 400 | | Magnesii Stearas | | | Polysorbatum 80 | | | Povidonum K | 30 | | Pro Compresso Obducto | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 30 | PR | PR | A | | No |
|
|